menaquinone-6 and Metabolic-Syndrome

menaquinone-6 has been researched along with Metabolic-Syndrome* in 2 studies

Other Studies

2 other study(ies) available for menaquinone-6 and Metabolic-Syndrome

ArticleYear
Vitamin K2 Improves Anxiety and Depression but not Cognition in Rats with Metabolic Syndrome: a Role of Blood Glucose?
    Folia medica, 2016, 12-01, Volume: 58, Issue:4

    The metabolic syndrome is a socially important disorder of energy utilization and storage, recognized as a factor predisposing to the development of depression, anxiety and cognitive impairment in humans.. In the present study we examined the effects of vitamin K2 on the behavior of rats with metabolic syndrome and looked for relationships with the effects on blood sugar.. Male Wistar rats were divided in four groups: a control group on a regular rat chow, a metabolic syndrome (MS) group fed a high-fat high-fructose diet, a control group treated with vitamin K2 and a MS group treated with vitamin K2. Vitamin K2 was given by gavage. At the end of the study (after 10 weeks) behavioral tests were performed and fasting blood glucose was measured. Anxiety was determined using the social interaction test and depression was assessed by the Porsolt test. Memory effects were estimated by the object recognition test. Correlations between fasting blood glucose and behavioral performance were analyzed.. The rats from the MS group had elevated blood glucose. They had anxiety, depression and memory deficit. Vitamin K2 normalized blood glucose, reduced anxiety and depression, but did not improve memory. Time of social interaction (inverse index of anxiety) and memory recognition were negatively correlated with blood glucose in the untreated rats but the immobility time (measure of depression) was not. When vitamin K2-treated rats were added, the correlation of blood glucose with the time of social interaction was kept, but the one with the recognition memory was lost. It might be that the anxiolytic effect of vitamin K2 in this setting is at least partly due to its effects on blood glucose, while the anti-depressant effect is glucose-independent.. The present study demonstrated that vitamin K2 prevented the development of anxiety and depression, but did not improve the memory deficit caused by the dietary manipulation in an experimental model of metabolic syndrome. It might be that the anxiolytic effect of vitamin K2 is at least partly due to its effects on blood glucose, while the antidepressant effect is glucose-independent.

    Topics: Animals; Anxiety; Behavior, Animal; Blood Glucose; Cognition; Cognitive Dysfunction; Depression; Diet, High-Fat; Disease Models, Animal; Fructose; Male; Memory Disorders; Memory, Short-Term; Metabolic Syndrome; Rats; Rats, Wistar; Social Behavior; Vitamin K 2; Vitamins

2016
Association Between Vitamin K and the Metabolic Syndrome: A 10-Year Follow-Up Study in Adults.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:6

    The Metabolic Syndrome (MetS) is a cluster of metabolic abnormalities and is associated with increased risk of diabetes and cardiovascular diseases. Phylloquinone, menaquinones, and vitamin K status are associated with several components of MetS, but the association with MetS has hardly been studied to date.. This study aimed to examine whether the intake and/or status of vitamin K is associated with MetS and its components.. This study comprised two cohorts, one of 402 women and one of 400 men (age 40-80 y). At followup 625 participants were still alive and willing to participate. Data were analyzed both cross sectionally and longitudinally with Poisson and linear regression adjusted for multiple confounders. Baseline phylloquinone/menaquinone intakes were measured with a validated food frequency questionnaire and vitamin K status with serum desphospho-uncarborxylated matrix-Gla protein level.. At baseline 270 (34.5%) participants had MetS and 171 (35.7%) at followup. Cross sectionally, high menaquinones intakes were associated (P(trend) = .08) with a lower prevalence of MetS with a prevalence ratio (PR) of 0.74 (95% confidence interval [CI], 0.54-1.03) for the highest vs the lowest tertile. At followup, the highest tertiles of menaquinones intake (PR = 0.62; 95% CI, 0.40-0.95) and vitamin K status (PR = 0.57; 95% CI, 0.38-0.87) were associated (P(trend) = .01) with a lower occurrence of MetS. These associations were mainly driven by relations with lower triacylglycerol concentrations for menaquinones and lower waist circumference for vitamin K status. Phylloquinone intake was not associated with MetS prevalence.. This study shows that a high intake of menaquinones and high vitamin K status are associated with a lower occurrence of MetS.

    Topics: Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Diet Surveys; Eating; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Vitamin K; Vitamin K 1; Vitamin K 2

2015